Reacción #1702031

ord-b59c5040c4d74c4eba154504c0cb4c58

Ecuación de reacción

CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1.Cl
topotecan hydrochloride
[Na]
sodium
N[C@@H](CS(=O)(=O)O)C(=O)O
cysteic acid
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1
topotecan

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Otroevaporated in vacuo
  2. 2
    workup.ADDITION120 ml sodium chloride solution (9 mg/ml) was added to the residue
  3. 3
    Otroobtained
  4. 4
    Otroafter evaporation
  5. 5
    Otrotransparent (approx. 20 min)
  6. 6
    OtroThe solution obtained
  7. 7
    Filtraciónwas filtered through 0.2 mm
  8. 8
    Filtraciónfilter
  9. 9
    FiltraciónThe filtration

Procedimiento

Methanol stock-solutions of topotecan hydrochloride (120 ml, 1.09 mg/ml) and sodium salt of methyl ester of N-all-trans-retinoyl cysteic acid (32 ml, 15 mg/ml) were mixed in a 500 ml round-bottom flask and evaporated in vacuo. 120 ml sodium chloride solution (9 mg/ml) was added to the residue obtained after evaporation, and the mixture was stirred until it became clear and transparent (approx. 20 min). The concentration of topotecan in the obtained solution was 1 mg/ml, corresponding to a topotecan hydrochloride concentration of 1.09 mg/ml. The solution obtained was filtered through 0.2 mm filter. The filtration did not result in reduction of topotecan concentration.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US08765173B2uspto-grants-2014_07